WinSanTor Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$707K
- Investors
-
6
WinSanTor General Information
Description
Operator of a biotechnology company intended to develop treatments for peripheral neuropathy. The company's biotechnology development discovers a novel pathway resulting in neuroprotection and neuroregeneration of degenerating neurons and patents the new formulation with novel indications, enabling patients to prevent and reverse nerve damage caused by diabetes.
Contact Information
Website
www.winsantor.comCorporate Office
- 7220 Trade Street
- Suite 370
- San Diego, CA 92121
- United States
Corporate Office
- 7220 Trade Street
- Suite 370
- San Diego, CA 92121
- United States
WinSanTor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Equity Crowdfunding | 01-Apr-2024 | $707K | Completed | Clinical Trials - Phase 3 | ||
| 13. Later Stage VC | 31-Dec-2021 | Completed | Clinical Trials - Phase 3 | |||
| 12. Grant | 01-Sep-2021 | Completed | Clinical Trials - Phase 3 | |||
| 11. Grant | 30-Sep-2020 | Completed | Clinical Trials - Phase 2 | |||
| 10. Accelerator/Incubator | 01-Jan-2020 | Completed | Clinical Trials - Phase 2 | |||
| 9. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 8. Equity Crowdfunding | 20-Mar-2019 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 20-Sep-2018 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC | 16-Nov-2017 | $1.35M | $1.35M | Completed | Clinical Trials - Phase 1 | |
| 5. Grant | 23-May-2017 | $3.71M | Completed | Pre-Clinical Trials |
WinSanTor Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
WinSanTor Patents
WinSanTor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023207084-A1 | Compositions and methods for improving sexual sensory disorders | Pending | 16-Jan-2022 | ||
| EP-4463234-A1 | Compositions and methods for improving sexual sensory disorders | Pending | 16-Jan-2022 | ||
| EP-4463234-A4 | Compositions and methods for improving sexual sensory disorders | Pending | 16-Jan-2022 | ||
| US-20240358712-A1 | Compositions and methods for improving sexual sensory disorders | Pending | 16-Jan-2022 | ||
| WO-2023137098-A1 | Compositions and methods for improving sexual sensory disorders | Inactive | 16-Jan-2022 | A61K31/5513 |
WinSanTor Signals
WinSanTor Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Methuselah Foundation | Not-For-Profit Venture Capital | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | Minority | ||
| Angel (individual) | Minority | |||
| Methuselah Fund | Venture Capital | Minority | ||
| Thynk Capital | Venture Capital | Minority |
WinSanTor FAQs
-
When was WinSanTor founded?
WinSanTor was founded in 2011.
-
Where is WinSanTor headquartered?
WinSanTor is headquartered in San Diego, CA.
-
What is the size of WinSanTor?
WinSanTor has 16 total employees.
-
What industry is WinSanTor in?
WinSanTor’s primary industry is Drug Discovery.
-
Is WinSanTor a private or public company?
WinSanTor is a Private company.
-
What is WinSanTor’s current revenue?
The current revenue for WinSanTor is .
-
How much funding has WinSanTor raised over time?
WinSanTor has raised $2.66M.
-
Who are WinSanTor’s investors?
Methuselah Foundation, CONNECT (San Diego), , Methuselah Fund, and Thynk Capital are 5 of 6 investors who have invested in WinSanTor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process